Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2021
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
Mikael Eriksson, Martin Eklund, Signe Borgquist, et al.
Trials
|
June 27, 2020
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
Plos Pathogens
|
June 23, 2017
Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways
Saskia Scholz, Faezzah Baharom, Gregory Rankin, et al.
The Journal of Urology
|
July 8, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial
Hari T Vigneswaran, Martin Eklund, Andrea Discacciati, et al.
The Journal of Urology
|
April 9, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
European Urology Oncology
|
April 22, 2025
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
BMJ Open
|
June 6, 2022
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
Daniel Clark Files, Michael A Matthay, Carolyn S Calfee, et al.
Nature Medicine
|
August 28, 2024
Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Nature Medicine
|
August 20, 2024
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2021
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
Mikael Eriksson, Martin Eklund, Signe Borgquist, et al.
Trials
|
June 27, 2020
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
Plos Pathogens
|
June 23, 2017
Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways
Saskia Scholz, Faezzah Baharom, Gregory Rankin, et al.
The Journal of Urology
|
July 8, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial
Hari T Vigneswaran, Martin Eklund, Andrea Discacciati, et al.
The Journal of Urology
|
April 9, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
European Urology Oncology
|
April 22, 2025
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial
Alessio Crippa, Bram De Laere, Andrea Discacciati, et al.
BMJ Open
|
June 6, 2022
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
Daniel Clark Files, Michael A Matthay, Carolyn S Calfee, et al.
Nature Medicine
|
August 28, 2024
Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Nature Medicine
|
August 20, 2024
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Page
of 8